Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

Xingjian Li, Daniel T. Payne, Badarinath Ampolu, Nicholas Bland, Jane T. Brown, Mark J. Dutton, Catherine A. Fitton, Abigail Gulliver, Lee Hale, Daniel Hamza, Geraint Jones, Rebecca Lane, Andrew G. Leach, Louise Male, Elena G. Merisor, Michael J. Morton, Alex S. Quy, Ruth Roberts, Rosanna Scarll, Timothy Schulz-Utermoehl, Tatjana Stankovic, Brett Stevenson, John S. Fossey, Angelo Agathanggelou

Open source

DOI: 10.1039/c9md00297a
Published: 2019
Container: MedChemComm
Publisher: Royal Society of Chemistry (RSC)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/c9md00297a,
  title = {Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia},
  author = {Xingjian Li and Daniel T. Payne and Badarinath Ampolu and Nicholas Bland and Jane T. Brown and Mark J. Dutton and Catherine A. Fitton and Abigail Gulliver and Lee Hale and Daniel Hamza and Geraint Jones and Rebecca Lane and Andrew G. Leach and Louise Male and Elena G. Merisor and Michael J. Morton and Alex S. Quy and Ruth Roberts and Rosanna Scarll and Timothy Schulz-Utermoehl and Tatjana Stankovic and Brett Stevenson and John S. Fossey and Angelo Agathanggelou},
  year = {2019},
  journal = {MedChemComm},
  doi = {10.1039/c9md00297a},
  url = {https://doi.org/10.1039/c9md00297a}
}

RIS

TY  - JOUR
TI  - Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
AU  - Xingjian Li
AU  - Daniel T. Payne
AU  - Badarinath Ampolu
AU  - Nicholas Bland
AU  - Jane T. Brown
AU  - Mark J. Dutton
AU  - Catherine A. Fitton
AU  - Abigail Gulliver
AU  - Lee Hale
AU  - Daniel Hamza
AU  - Geraint Jones
AU  - Rebecca Lane
AU  - Andrew G. Leach
AU  - Louise Male
AU  - Elena G. Merisor
AU  - Michael J. Morton
AU  - Alex S. Quy
AU  - Ruth Roberts
AU  - Rosanna Scarll
AU  - Timothy Schulz-Utermoehl
AU  - Tatjana Stankovic
AU  - Brett Stevenson
AU  - John S. Fossey
AU  - Angelo Agathanggelou
PY  - 2019
JO  - MedChemComm
DO  - 10.1039/c9md00297a
UR  - https://doi.org/10.1039/c9md00297a
ER  -

APA

Li, X., Payne, D. T., Ampolu, B., Bland, N., Brown, J. T., Dutton, M. J., Fitton, C. A., Gulliver, A., Hale, L., Hamza, D., Jones, G., Lane, R., Leach, A. G., Male, L., Merisor, E. G., Morton, M. J., Quy, A. S., Roberts, R., Scarll, R., Schulz-Utermoehl, T., Stankovic, T., Stevenson, B., Fossey, J. S., & Agathanggelou, A. (2019). Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia. MedChemComm. https://doi.org/10.1039/c9md00297a

Source records

crossref · retrieved 2026-11-10T20:59:46.068Z